Clinical Trials in Seattle

Showing 5461-5480 of 9,312 trials

Cancer Communication Within Hispanic Social Networks

NCT04444232

This trial examines cancer communication within Hispanic social networks. Hispanics have the lowest colorectal cancer screening rate of any major ethnic group and health interventions are crucially needed among Hispanics. Patient decision aids are health communication interventions designed to provide patients with targeted health information and have shown to improve colorectal cancer screening rates among Hispanics. The goal of this study is to investigate, in a sample of Hispanics, how a colorectal cancer decision aid aimed at increasing individuals' colorectal cancer screening behavior has effects on their alters' intention to get screened for colorectal cancer.

Colorectal Carcinoma

Fred Hutchinson Cancer Center57 participantsStarted Sep 2014

Seattle, Washington, United States

COMPLETEDPhase 2< 1 mile

Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

NCT01993186

The primary objectives of the study are to evaluate the efficacy of UX007 compared to placebo as measured by the reduction from randomization to Week 8 in frequency of seizures and to evaluate the safety of UX007 via adverse event (AE) rates, laboratory values, and electrocardiogram (ECG).

Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Ultragenyx Pharmaceutical Inc36 participantsStarted Feb 2014

Aurora, Colorado, United States • Miami, Florida, United States • Orlando, Florida, United States +11 more locations

Cancer Communication Within Hispanic Social Networks

Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Find Trials by Condition in Seattle

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC

Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF

NATRELLE® 410 X-Style and L-Style Breast Implants Continued Access Study

Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder

Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain

Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis

A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

Why do Oral Contraceptives Prevent Ovarian Cancer?

Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer

Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH

A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and Lymphomas

Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease